Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Arké SMO S.A. de C.V. (Site 0706)

Mexico City, Mexico City, MexicoNot linked to an institution yet

1running trial
0closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

Active, not recruiting
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
NCT06305754· Phase 3· Source

Researchers

No researcher is linked here yet.

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error

Under construction, not live – Arké SMO S.A. de C.V. (Site 0706): trial site – Frontlight Research